 Vibha Sharma
Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thyroid Neoplasms | 11 | 2023 | 262 | 1.300 |
Why?
| | Retinoid X Receptors | 7 | 2011 | 39 | 0.610 |
Why?
| | Retinoids | 5 | 2011 | 31 | 0.530 |
Why?
| | Thyroid Gland | 3 | 2011 | 83 | 0.400 |
Why?
| | Thyroid Carcinoma, Anaplastic | 2 | 2023 | 34 | 0.380 |
Why?
| | Receptors, Calcitriol | 1 | 2010 | 53 | 0.360 |
Why?
| | Calcitriol | 1 | 2010 | 53 | 0.350 |
Why?
| | Pituitary Gland | 2 | 2011 | 152 | 0.330 |
Why?
| | Hypothalamus | 2 | 2011 | 150 | 0.330 |
Why?
| | Receptors, Retinoic Acid | 3 | 2004 | 50 | 0.300 |
Why?
| | Cell Line, Tumor | 11 | 2019 | 2751 | 0.220 |
Why?
| | Carcinoma | 3 | 2009 | 200 | 0.210 |
Why?
| | Proto-Oncogene Proteins B-raf | 2 | 2023 | 192 | 0.190 |
Why?
| | Transcription Factors | 2 | 2004 | 1528 | 0.160 |
Why?
| | Focal Adhesion Kinase 1 | 2 | 2016 | 27 | 0.160 |
Why?
| | Adenocarcinoma, Follicular | 1 | 2019 | 34 | 0.160 |
Why?
| | Gene Expression | 1 | 2004 | 1436 | 0.160 |
Why?
| | Adrenal Cortex | 1 | 2018 | 32 | 0.150 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 228 | 0.150 |
Why?
| | Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2018 | 31 | 0.150 |
Why?
| | Adrenal Cortex Neoplasms | 1 | 2018 | 48 | 0.140 |
Why?
| | Adrenocortical Carcinoma | 1 | 2018 | 47 | 0.140 |
Why?
| | Benzoates | 3 | 2009 | 38 | 0.140 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 178 | 0.140 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 4 | 2014 | 930 | 0.140 |
Why?
| | Thiazolidinediones | 2 | 2009 | 143 | 0.130 |
Why?
| | Protein-Tyrosine Kinases | 1 | 2019 | 396 | 0.130 |
Why?
| | Antineoplastic Agents | 4 | 2012 | 1893 | 0.120 |
Why?
| | Genes, Tumor Suppressor | 1 | 2014 | 78 | 0.110 |
Why?
| | Thiazoles | 1 | 2012 | 110 | 0.100 |
Why?
| | src-Family Kinases | 1 | 2012 | 88 | 0.100 |
Why?
| | Tetrahydronaphthalenes | 2 | 2009 | 31 | 0.090 |
Why?
| | Steroid Hydroxylases | 1 | 2010 | 19 | 0.090 |
Why?
| | Deoxyribonucleases, Type II Site-Specific | 1 | 2010 | 17 | 0.090 |
Why?
| | Cell Survival | 2 | 2012 | 1024 | 0.090 |
Why?
| | Vitamin D3 24-Hydroxylase | 1 | 2010 | 14 | 0.090 |
Why?
| | 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2010 | 16 | 0.090 |
Why?
| | Blotting, Western | 3 | 2014 | 1153 | 0.090 |
Why?
| | Mice | 9 | 2019 | 15052 | 0.090 |
Why?
| | Thyroxine | 2 | 2011 | 59 | 0.090 |
Why?
| | Bone Neoplasms | 1 | 2012 | 194 | 0.090 |
Why?
| | Carrier Proteins | 1 | 2014 | 701 | 0.090 |
Why?
| | Cell Proliferation | 6 | 2019 | 2194 | 0.090 |
Why?
| | MAP Kinase Kinase 2 | 1 | 2009 | 27 | 0.080 |
Why?
| | Proto-Oncogene Proteins pp60(c-src) | 1 | 2009 | 11 | 0.080 |
Why?
| | MAP Kinase Kinase 1 | 1 | 2009 | 66 | 0.080 |
Why?
| | Pyrimidines | 1 | 2012 | 376 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2010 | 638 | 0.080 |
Why?
| | Focal Adhesion Protein-Tyrosine Kinases | 1 | 2009 | 27 | 0.080 |
Why?
| | RNA, Messenger | 3 | 2005 | 2574 | 0.080 |
Why?
| | Dasatinib | 2 | 2023 | 46 | 0.080 |
Why?
| | Carcinoma, Papillary | 1 | 2009 | 73 | 0.080 |
Why?
| | Benzodioxoles | 1 | 2009 | 83 | 0.080 |
Why?
| | MAP Kinase Signaling System | 1 | 2009 | 275 | 0.070 |
Why?
| | Quinazolines | 1 | 2009 | 241 | 0.070 |
Why?
| | Polymorphism, Genetic | 1 | 2010 | 621 | 0.070 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 1 | 2009 | 195 | 0.070 |
Why?
| | PPAR gamma | 2 | 2009 | 185 | 0.070 |
Why?
| | Vitamin D | 1 | 2010 | 341 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2114 | 0.070 |
Why?
| | Mice, Nude | 3 | 2016 | 639 | 0.070 |
Why?
| | Tumor Cells, Cultured | 2 | 2009 | 850 | 0.070 |
Why?
| | Iodide Peroxidase | 1 | 2005 | 27 | 0.070 |
Why?
| | Thyrotropin | 1 | 2005 | 100 | 0.060 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2005 | 129 | 0.060 |
Why?
| | Animals | 9 | 2019 | 32104 | 0.060 |
Why?
| | Heterografts | 2 | 2016 | 119 | 0.060 |
Why?
| | Retinoid X Receptor gamma | 1 | 2004 | 4 | 0.060 |
Why?
| | Mutation | 2 | 2019 | 3364 | 0.060 |
Why?
| | Organic Chemicals | 1 | 2005 | 116 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2009 | 1147 | 0.060 |
Why?
| | Lipoprotein Lipase | 1 | 2004 | 55 | 0.060 |
Why?
| | Transfection | 1 | 2005 | 866 | 0.060 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2023 | 76 | 0.050 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2012 | 704 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2004 | 339 | 0.050 |
Why?
| | Apoptosis | 3 | 2012 | 2377 | 0.050 |
Why?
| | Melanoma | 1 | 2009 | 651 | 0.050 |
Why?
| | Humans | 13 | 2023 | 115741 | 0.050 |
Why?
| | Dietary Fats | 1 | 2004 | 289 | 0.050 |
Why?
| | Cell Division | 1 | 2004 | 759 | 0.050 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 1870 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2023 | 400 | 0.050 |
Why?
| | Promoter Regions, Genetic | 1 | 2005 | 1122 | 0.050 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 1361 | 0.050 |
Why?
| | Cell Cycle | 1 | 2004 | 546 | 0.050 |
Why?
| | Mice, Transgenic | 1 | 2005 | 1970 | 0.050 |
Why?
| | Cell Line | 1 | 2005 | 2651 | 0.040 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2014 | 746 | 0.040 |
Why?
| | Neoplasm Transplantation | 1 | 2019 | 235 | 0.040 |
Why?
| | Aldosterone | 1 | 2018 | 42 | 0.040 |
Why?
| | Liver | 1 | 2005 | 1690 | 0.040 |
Why?
| | Germ-Line Mutation | 1 | 2018 | 131 | 0.040 |
Why?
| | Cell Growth Processes | 1 | 2016 | 52 | 0.030 |
Why?
| | Phosphorylation | 2 | 2012 | 1571 | 0.030 |
Why?
| | Signal Transduction | 3 | 2016 | 4541 | 0.030 |
Why?
| | Time Factors | 1 | 2005 | 6171 | 0.030 |
Why?
| | Ligands | 2 | 2009 | 569 | 0.030 |
Why?
| | Muscle, Skeletal | 1 | 2004 | 1447 | 0.030 |
Why?
| | Carcinogenesis | 1 | 2016 | 178 | 0.030 |
Why?
| | Neoplasm Metastasis | 1 | 2016 | 526 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 114 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2012 | 84 | 0.020 |
Why?
| | Thyrotropin, beta Subunit | 1 | 2011 | 5 | 0.020 |
Why?
| | Glycoprotein Hormones, alpha Subunit | 1 | 2011 | 22 | 0.020 |
Why?
| | Tumor Burden | 1 | 2012 | 261 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2011 | 77 | 0.020 |
Why?
| | Protein Processing, Post-Translational | 1 | 2012 | 401 | 0.020 |
Why?
| | Immunohistochemistry | 1 | 2014 | 1642 | 0.020 |
Why?
| | Butadienes | 1 | 2009 | 31 | 0.020 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2009 | 180 | 0.020 |
Why?
| | Nitriles | 1 | 2009 | 152 | 0.020 |
Why?
| | Benzamides | 1 | 2009 | 168 | 0.020 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2009 | 166 | 0.020 |
Why?
| | Male | 3 | 2012 | 56050 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2009 | 793 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2009 | 544 | 0.020 |
Why?
| | Cell Culture Techniques | 1 | 2009 | 344 | 0.020 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 301 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2009 | 757 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2011 | 1310 | 0.020 |
Why?
| | Luciferases | 1 | 2004 | 140 | 0.010 |
Why?
| | Immunoprecipitation | 1 | 2004 | 154 | 0.010 |
Why?
| | Protein Binding | 1 | 2009 | 1917 | 0.010 |
Why?
| | Protein Kinase Inhibitors | 1 | 2009 | 790 | 0.010 |
Why?
| | Female | 2 | 2019 | 60018 | 0.010 |
Why?
| | Weight Gain | 1 | 2004 | 453 | 0.010 |
Why?
| | Aged | 1 | 2019 | 19294 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 27069 | 0.010 |
Why?
|
|
Sharma's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|